Screening‐guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at‐risk patients

Machine Learning of ECG Waveforms to Improve Selection for Testing for Asymptomatic Left Ventricular Dysfunction

(2021) Elizabeth L. Potter et al.   JACC-Cardiovascular Imaging

Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes

(2021) Niels H. Brandt-Jacobsen et al.   JACC-Heart Failure

Spironolactone dose in Heart Failure with Preserved Ejection Fraction: findings from TOPCAT

(2020) João Pedro Ferreira et al.   EUROPEAN JOURNAL OF HEART FAILURE

Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology

(2020) Nathan Mewton et al.   Archives of Cardiovascular Diseases

10-Year Risk Equations for Incident Heart Failure in the General Population

(2019) Sadiya S. Khan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial)

(2019) Marie L. Johansen et al.   DIABETES OBESITY & METABOLISM

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction

(2019) Adam K. McDiarmid et al.   Journal of the American Heart Association

Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals

(2018) Nathalie Conrad et al.   LANCET

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2017) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure

(2017) Hong Yang et al.   JACC-Cardiovascular Imaging

Community Screening for Nonischemic Cardiomyopathy in Asymptomatic Subjects ≥65 Years With Stage B Heart Failure

(2016) Hong Yang et al.   AMERICAN JOURNAL OF CARDIOLOGY

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

(2016) Gerasimos Filippatos et al.   EUROPEAN HEART JOURNAL

Should We Start Community Screening for Left Ventricular Dysfunction?

(2016) Paul A. Heidenreich   JOURNAL OF CARDIAC FAILURE

Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneClinical Perspective

(2015) Amil M. Shah et al.   CIRCULATION

Population Risk Prediction Models for Incident Heart Failure: A Systematic Review

(2015) J. B. Echouffo-Tcheugui et al.   Circulation-Heart Failure

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction

(2014) Kashif Kalam et al.   HEART

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Forecasting the Impact of Heart Failure in the United States

(2013) Paul A. Heidenreich et al.   Circulation-Heart Failure

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

(2013) Bertram Pitt et al.   EUROPEAN HEART JOURNAL

Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade

(2013) Wojciech Kosmala et al.   HEART

Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

(2013) Frank Edelmann et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prediction of Incident Heart Failure in General Practice

(2012) Sunil K. Agarwal et al.   Circulation-Heart Failure

Normal Ranges of Left Ventricular Strain: A Meta-Analysis

(2012) Teerapat Yingchoncharoen et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease

(2011) Nicola C. Edwards et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure

(2011) Garvan C. Kane et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome

(2011) Wojciech Kosmala et al.   JACC-Cardiovascular Imaging

Effect of Spironolactone on Left Ventricular Ejection Fraction and Volumes in Patients With Class I or II Heart Failure

(2010) Enrico Vizzardi et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Development of Heart Failure in Patients With Diabetes Mellitus and Pre-Clinical Diastolic Dysfunction

(2010) Aaron M. From et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data

(2009) Sudeep Karve et al.   CURRENT MEDICAL RESEARCH AND OPINION